Bitget App
Trade smarter
MarketsTradeFuturesEarnSquareMore
Zcash News Today: ZEC Whale Risks $5M as Collateral—Will the Short Position Hold if Privacy Coins Surge?

Zcash News Today: ZEC Whale Risks $5M as Collateral—Will the Short Position Hold if Privacy Coins Surge?

Bitget-RWA2025/11/19 08:52
By:Bitget-RWA

- A ZEC short whale on Hyperliquid faces $13.77M losses as Zcash surges past $700, with 10x leverage and a $1,084 liquidation price. - The whale added $5M USDC collateral to sustain the position, expanding the short size to $43.2M amid ZEC's 1,500% October-November rally. - ZEC's rise to $11.2B market cap, driven by institutional interest and privacy coin adoption, highlights risks of leveraged bets in volatile crypto markets. - The position reflects broader on-chain dynamics, with the whale also holding p

The largest

short on Hyperliquid, a leading crypto derivatives platform, as of November 19, according to blockchain analytics provider Lookonchain. This position, initiated at $360 per (ZEC) in late October, has come under increasing strain as the token’s value soared above $700, . The trader has already lost over $536,000 to funding fees alone, .

The address 0xd47...51A91, which holds the short, is using 10x leverage and faces liquidation if ZEC hits $1,084. Despite mounting losses, the trader has

, including a $5 million deposit on November 16 to support the position. By averaging down, the short has grown from $29.26 million in early November to $43.2 million by November 19, during that time. This address has been holding the position since October 10, initially entering at just $184, and has steadily increased exposure as ZEC’s price has surged .

ZEC’s price movement has been a major factor in the short’s difficulties. The token

in late November after soaring 1,500% since October, making it the 12th-largest crypto by market cap, now exceeding $11.2 billion. The rally has attracted institutional interest, , who revealed ZEC is the second-largest liquid holding in his family office, Maelstrom. Meanwhile, biotech company Leap Therapeutics , a ZEC treasury firm, with support from the Winklevoss twins, further boosting market excitement.

Zcash News Today: ZEC Whale Risks $5M as Collateral—Will the Short Position Hold if Privacy Coins Surge? image 0

The challenges faced by this short reflect broader trends in on-chain activity. Hyperliquid’s records show the same trader also holds a 15x leveraged ETH short valued at $26 million,

, along with several leveraged shorts in and . However, the ZEC short remains the riskiest, with its liquidation threshold now only 34% above the current $686 price. on whether ZEC retreats from its recent highs, a scenario that seems less likely as privacy coins gain renewed attention and debates continue over Bitcoin’s OP_CAT opcode.

The persistence of this short underscores the dangers of high leverage in fast-moving markets. While the trader has so far avoided liquidation by aggressively adding collateral, any further rise in ZEC could force a partial or complete exit. This situation reflects a wider market pattern, where leveraged traders are being challenged as privacy-focused cryptocurrencies like ZEC gain momentum amid regulatory and technological developments.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Adobe’s Semrush Acquisition: AI Growth Push Raises Valuation Questions

- Adobe nears $1.9B Semrush acquisition, doubling its share price in pre-market trading amid valuation debates. - The deal aims to expand Adobe's AI-driven marketing tools, addressing AI's impact on its creative software business. - Analysts highlight Adobe's 24.9% 2025 stock decline but argue it's undervalued based on DCF analysis and PE ratio comparisons. - Semrush's AI SEO tools and Adobe's recent revenue forecast raise hopes for integration success despite past Figma acquisition challenges.

Bitget-RWA2025/11/19 13:38
Adobe’s Semrush Acquisition: AI Growth Push Raises Valuation Questions

Silver Faces Setbacks: Hopes for Rate Cuts and Industrial Challenges Put Metal's Strength to the Test

- Silver prices rose 0.45% on Nov 19, 2025, but remained 12.7% below their October peak amid Fed rate cut expectations and weak industrial demand. - Analysts highlight key support/resistance levels (₹1,55,000–₹1,62,000) and note Fed policy and global economic recovery will drive near-term volatility. - Aya Gold & Silver aims to monetize silver-rich stockpiles in Morocco, reflecting industry efforts to optimize by-product recovery amid fluctuating prices. - Long-term optimism persists due to silver's dual r

Bitget-RWA2025/11/19 13:38
Silver Faces Setbacks: Hopes for Rate Cuts and Industrial Challenges Put Metal's Strength to the Test

Hyperliquid News Today: Paxos Introduces USDG0: Compliant Cross-Chain Liquidity Without Bridge-Related Risks

- Paxos launches USDG0, an omnichain stablecoin using LayerZero's OFT standard to provide regulated dollar liquidity across Hyperliquid, Plume, and Aptos. - The stablecoin eliminates bridge risks by operating as a single native asset, supporting yield-aligned trading pairs and modular DeFi infrastructure on target chains. - USDG0 aligns with global regulatory frameworks (GENIUS Act, MiCA) while addressing institutional demand for instant, compliant cross-chain transfers through partnerships like Trovata's

Bitget-RWA2025/11/19 13:38
Hyperliquid News Today: Paxos Introduces USDG0: Compliant Cross-Chain Liquidity Without Bridge-Related Risks

ARK's technology investments steer through hurdles in regulation and profitability

- ARK Invest, led by Cathie Wood, allocated $7.9M to Roblox shares on Nov 18, 2025, while reducing Pinterest holdings by $5.19M via ARKK and ARKF ETFs. - The firm expanded fintech exposure by acquiring Klarna ($3.25M) and Circle ($3.07M) shares, aligning with sector growth amid profitability concerns. - Biotech investments included $2.09M in Recursion and $2.64M in CRISPR Therapeutics , reflecting ongoing focus on gene-editing innovations. - A $7.2M sale of Teradyne shares signaled a strategic shift away f

Bitget-RWA2025/11/19 13:20
ARK's technology investments steer through hurdles in regulation and profitability